InnoCare Pharma (09969) issued 15,389,200 restricted share units.

date
21:18 24/04/2026
avatar
GMT Eight
Nuo Cheng Jianhua (09969) announced that on April 24, 2026, the company granted 15.3892 million restricted share units to 3 grantees under the 2023 equity incentive plan, equivalent to approximately 0.87% of the total number of shares issued by the company as of the date of this announcement (excluding treasury shares). The granting of restricted share units to the relevant executive directors is subject to approval by the shareholders at the upcoming annual general meeting.
InnoCare Pharma (09969) announced that on April 24, 2026, the company granted 15.3892 million restricted share units to three grantees under the 2023 equity incentive plan. This represents approximately 0.87% of the total number of shares issued by the company as of the date of this announcement (excluding treasury shares). The granting of restricted share units to certain executive directors is subject to approval by the shareholders at the upcoming annual general meeting before they can be realized.